Regarding prostate cancer, the results of Chang et al. reported that radioresistance in prostate cancer is related to epithelial–mesenchymal transition and improved cancer stem cell phenotypes via activation of the PI3K/Akt/mTOR signaling pathway [176]. This evidence concerns the gene MTOR and prostate carcinoma.